Many researchers demonstrated that p53 mutant isoforms increase overall ROS levels in cancer cells via an organized control of multiple redox-related enzymes and signaling pathways, thereby promoting cancer cell proliferation [59]. This evidence concerns the gene TP53 and cancer.